Drug
QCZ484 clinical trials
Also written QCZ484.
Keep track of what changes. Save the QCZ484 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses QCZ484 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant HypercholesterolemiaRecruitingPhase 2Novartis PharmaceuticalsNCT07610278Written as QCZ484
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.RecruitingPhase 2Novartis PharmaceuticalsNCT07543120Written as QCZ484
- A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive PatientsActive, not recruitingPhase 2Novartis PharmaceuticalsNCT06857955Written as QCZ484
- A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive SubjectsCompletedPhase 1Novartis PharmaceuticalsNCT06905327Written as QCZ484